Listen to HBW Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.
In this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility in the US of naloxone, a life-saving opioid overdose antidote. Hufford unpacks the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies currently producing prescription naloxone to make the switch to OTC status, and why many of them have chosen not to. While the financial incentive may not be there, the public health need is dire, and Hufford explains the importance of harm reduction groups and non-profit pharmaceutical companies for getting naloxone into the hands of those who need it the most.
Over The Counter 3 May 2022: Which COVID Trends Are Here To Stay? With IQVIA Consumer Health’s Prasanna Pitale
In this episode, HBW Insight talks to IQVIA Consumer Health’s Prasanna Pitale about the company's research on the recent self-care trends that will endure after COVID-19. Pitale points to wellness and prevention, Rx-to-OTC switch and naturals as drivers of long-term change in the global consumer health market. Sustainability and artificial intelligence are also noted as important disruptors that OTC companies need to act on if they are stay ahead of the pack in the years ahead.
Over The Counter 25 Apr 2022: Exploring The Intersection Of Skin Care, AI And Business With Revieve's Sampo Parkkinen
In this episode of Over The Counter, HBW Insight speaks to AI technology expert Sampo Parkkinen, CEO of Revieve, which helps its clients deliver personalized digital brand experiences. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Parkkinen also comments on Revieve’s space in the metaverse, and how businesses can leverage new technology to build relationships with consumers.
In this episode, HBW Insight editors look ahead to Q1 sales and earnings reports of the world’s largest consumer healthcare companies. We reflect on what has happened in the last 12 months during the COVID-19 pandemic, and what the next few months might bring for industry. The return of cough and cold, inflation, the war in Ukraine and OTC business spin-offs are all major trends shaping the market right now.
This episode of the Over The Counter podcast takes a bird’s eye view of sustainability in the cosmetics industry with HBW Insight editor Ryan Nelson. We discuss the drivers of sustainability efforts, such as consumer demand for more eco-friendly products and the growing social consciousness about climate change. How the beauty industry is using third-party regulatory groups to combat greenwashing is also covered, along with steps companies are taking to make their products more sustainable and the legislation in the US and EU that is putting pressure on businesses.
In this episode, HBW Insight catches up with Association of the European Self-Care Industry, AESGP, director general Jurate Švarcaite to discuss the association’s upcoming conference. The 58th Annual Meeting will be the first since the coronavirus pandemic to take place in person, with delegates set to convene in Madrid, Spain, from 7-8 June. Bringing together more than 300 representatives from the consumer health industry, partner organisations and policymakers, topics will include self-care market trends, regulatory innovations seen during COVID-19, sustainability and advertising. There will also be plenty of time for networking, something that has been sorely missed and is a key feature of AESGP Annual Meetings.
In this episode, HBW Insight speaks to self-care marketing expert Stuart Mayell about the hottest trends in UK consumer health. Based on interviews with a variety of consumer health clients, Mayell – who is Head of Creative Difference at the Difference Collective – confirms many of the trends seen elsewhere, such as a need for health literacy as consumers move online and an emphasis on wellness and prevention. But what is perhaps new is the way this focus on prevention is pushing consumers, especially within younger generations, away from individualism and towards pro-social choices. Pressures on income from inflation, war and climate change are also shaping consumer choices, he thinks. Consumer health brands must find their purpose, he advises, if they are to stand out from the crowded shelf and compete with cheaper, generic options.
In this episode, HBW Insight talks probiotics with David Pineda Ereño, founder of DPE International Consulting and consultant to the International Probiotics Association. Since 2006, no health claims for probiotics have been allowed by harmonized European Union regulations. Even the term "probiotic" is considered an unauthorized health claim by the European Commission. However, as Pineda Ereño explains, many EU member states, including Italy and Spain, are starting to go their own way, adopting a more liberal approach to this booming wellness market. We discuss what the future of EU probiotics regulation may hold, as well as some recent exciting scientific developments, pointing to the health benefits of these extremely popular products.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.